Abstract: A horizontal stabilizer assembly includes a stabilizer connector assembly having a center multi-spar box, a first horizontal stabilizer having a first multi-spar box connected to a first side of the center multi-spar box with a plurality of first lug and clevis connections, and a second horizontal stabilizer having a second multi-spar box connected to a second side of the center multi-spar box, opposite the first side, with a plurality of second lug and clevis connections.

Abstract: An aircraft has a vertical stabilizer having a multi-spar box and a base rib assembly secured to the multi-spar box. The base rib assembly has a pair of middle longitudinal lugs between a front and rear of the base rib assembly, a pair of front lateral lugs along the front of the base rib assembly, and a pair of rear lateral lugs along the rear of the base rib assembly. There are no lateral lugs between the pairs of middle lugs. A pair of middle clevises extend through corresponding apertures in an outer skin of the fuselage and are secured to one of the plurality of frame members and a plurality of retaining members are inserted through mounting holes in each middle longitudinal lug and mounting holes in each middle clevis to secure the vertical stabilizer to the aircraft fuselage.

Abstract: An aircraft has a vertical stabilizer with a multi-spar box and a base rib assembly secured to the multi-spar box. The base rib assembly has front longitudinal lugs, rear longitudinal lugs, and opposing middle longitudinal lugs. Front clevises corresponding to the front longitudinal lugs are secured to frame members of the fuselage of the aircraft and each has a first, second, and third mounting arms. Rear clevises corresponding to the rear longitudinal lugs are secured to frame members and each has a first, second, and third mounting arms. Middle clevises corresponding to the middle longitudinal lugs are secured to frame members and each has only first and second mounting arms. Retaining members inserted through mounting holes in each longitudinal lug and mounting holes in each corresponding clevis secures the vertical stabilizer to the fuselage.

Abstract: A horizontal stabilizer assembly includes a stabilizer connector assembly having a center multi-spar box, a first horizontal stabilizer having a first multi-spar box connected to a first side of the center multi-spar box with a plurality of first lug and clevis connections, and a second horizontal stabilizer having a second multi-spar box connected to a second side of the center multi-spar box, opposite the first side, with a plurality of second lug and clevis connections.

Abstract: An aircraft has a vertical stabilizer with a multi-spar box and a base rib assembly secured to the multi-spar box. The base rib assembly has front longitudinal lugs, rear longitudinal lugs, and opposing middle longitudinal lugs. Front clevises corresponding to the front longitudinal lugs are secured to frame members of the fuselage of the aircraft and each has a first, second, and third mounting arms. Rear clevises corresponding to the rear longitudinal lugs are secured to frame members and each has a first, second, and third mounting arms. Middle clevises corresponding to the middle longitudinal lugs are secured to frame members and each has only first and second mounting arms. Retaining members inserted through mounting holes in each longitudinal lug and mounting holes in each corresponding clevis secures the vertical stabilizer to the fuselage.

Abstract: An aircraft has a vertical stabilizer having a multi-spar box and a base rib assembly secured to the multi-spar box. The base rib assembly has a pair of middle longitudinal lugs between a front and rear of the base rib assembly, a pair of front lateral lugs along the front of the base rib assembly, and a pair of rear lateral lugs along the rear of the base rib assembly. There are no lateral lugs between the pairs of middle lugs. A pair of middle clevises extend through corresponding apertures in an outer skin of the fuselage and are secured to one of the plurality of frame members and a plurality of retaining members are inserted through mounting holes in each middle longitudinal lug and mounting holes in each middle clevis to secure the vertical stabilizer to the aircraft fuselage.

Abstract: The present invention provides for reagents for the introduction of colorimetric-oxycarbonyl protecting groups, compounds bearing colorimetric-oxycarbonyl protecting groups, and the use thereof in solid-supported organic syntheses of oligonucleotides, polypeptides, polysaccharides, and combinatorial libraries.

Abstract: The specification discloses quenchers of excited state energy, probes and other conjugates comprising the same, and methods for their use. The quenchers of excited state energy have a structure comprising at least one reactive functional group for linking the quencher to a carrier molecule and at least three radicals covalently linked via exocyclic diazo bonds, the at least three radicals including at least one comprising a julolidine of the nominal formula: and the remainder of the at least three radicals being selected from the group of substituted and unsubstituted aryls, substituted and unsubstituted heteroaryls, and combinations thereof.

Abstract: The present invention provides for reagents for the introduction of colorimetric-oxycarbonyl protecting groups, compounds bearing colorimetric-oxycarbonyl protecting groups, and the use thereof in solid-supported organic syntheses of oligonucleotides, polypeptides, polysaccharides, and combinatorial libraries.

Abstract: Fluorous-tagged oligonucleotide reagents and an oligonucleotide purification methodology making use thereof, the method comprising: Synthesizing oligonucleotides using oligonucleotide reagents each bearing at least one fluorous group to yield a mixture of synthesis products and reagents, the mixture including at least one target synthesized oligonucleotide bearing at least one fluorous group; passing the mixture through a separation medium having an affinity for the at least one fluorous group so that the target synthesized oligonucleotide bearing at least one fluorous group is adsorbed by the separation medium; washing the separation medium with at least a first solvent to selectively dissociate therefrom substantially all synthesis products and reagents of the heterogenous mixture other than the at least one target synthesized oligonucleotide bearing at least one fluorous group; and subsequently dissociating the at least one synthesized oligonucleotide from the separation medium, with or without the fluorou

Abstract: This invention relates to 6 or 7 substituted swainsonine analogues, processes for their preparation and use as therapeutic agents. The invention also relates to pharmaceutical compositions containing the compounds and their use as therapeutics.

Abstract: Compound of the formula (I): wherein: R is defined in the specification; each R′, independently of the other, is H, acetyl, benzyl, methoxymethyl, tosyl, mesyl, trifluoromesyl, tri(C1-4 alkyl)silyl, di(C1-4 alkyl)phenylsilyl, diphenyl(C1-4 alkyl)silyl, or triphenylsilyl, or both R together from an alkylidene protecting group; R″ is H, acetyl, benzyl, methoxymethyl, tosyl, mesyl, trifluoromesyl, tri(C1-4 alkyl)silyl, di(C1-4 alkylsilyl)phenylsilyl, diphenyl(C1-4 alkyl)silyl, or triphenylsilyl; X is H, Cl, Br, or R4 (where R4 is C1-22-alkyl); Y is H, Cl, Br, or —CHR2OH, —CR2R3OH, —CH2CHR2OH, —CH2CR2R3OH, —SR2, —SeR2, —OH, —NH2, —R5 (where R2, R3, and R5 are independently of each other C1-22-alkyl); or X and Y together form a covalent bond; A and A′ are both H or together A and A′ form ═O, are useful as anticancer agents and as glycosidase inhibitors.

Abstract: (-)-Swainsonine may be prepared by (i) reacting a compound of formula (8): ##STR1## wherein OMs is methanesulfonyl with H.sub.2 in the presence of Pd(OH).sub.

Abstract: A stable, non-irritating composition and method for treating, without side effects, acute or chronic rhinosinusitis and its associated upper airway symptoms. The composition and treatment are useful for relieving the symptoms, and shortening the duration, of acute or chronic rhinosinusitis. The composition comprises a therapeutically effective solution having a pH of about 6.0, of ascorbic acid and caffeine, in combination with other soluble vitamins, natural ingredients and preservatives in a pharmaceutically acceptable carrier. The method includes the steps of preparing and administering the composition to the nasal membranes of a patient in the form of a nasal spray or drops.